Patents Assigned to Medical Foundation of Buffalo, Inc.
  • Patent number: 5400741
    Abstract: A varisized diffusion cell device (10) comprising a plurality of diffusion cells (18) arranged in rows (20A) to (20F) having progressively greater depths for growing high quality, diffraction grade crystals, is described. In use, the diffusion cells receive a quantity of crystallizing agent (32) that dissolves and diffuses through a head of solvent solution (34) to equilibrate with a drop (38) containing a subject macro-molecular material for growing crystals. The various depths of the diffusion cells provide various diffusion rates and therefore various equilibration rates. Through empirical methods, an optimum diffusion rate for a given crystal growth system can easily be determined.
    Type: Grant
    Filed: May 21, 1993
    Date of Patent: March 28, 1995
    Assignee: Medical Foundation of Buffalo, Inc.
    Inventors: George T. DeTitta, Joseph R. Luft
  • Patent number: 4997827
    Abstract: A composition for in vivo inhibition of aromatase in a mammal, which comprises an in vivo inhibitory amount of a compound having the following general formula: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1-20 acyl, in combination with a pharmaceutically acceptable carrier or diluent thereof.
    Type: Grant
    Filed: March 9, 1989
    Date of Patent: March 5, 1991
    Assignee: Medical Foundation of Buffalo, Inc.
    Inventor: Yoshio Osawa
  • Patent number: 4978658
    Abstract: A composition for in vivo inhibition of aromatase in a mammal, which comprises an in vivo inhibitory amount of a compound having the following general formula: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1-4 acyl, in combination with as pharmaceutically acceptable carrier or diluent thereof.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: December 18, 1990
    Assignee: Medical Foundation of Buffalo, Inc.
    Inventor: Yoshio Osawa
  • Patent number: 4829059
    Abstract: A composition for in vivo inhibition of aromatase in a mammal, which comprises an in vivo inhibitory amount of a compound having the following general formula: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1-4 acyl, in combination with a pharmaceutically acceptable carrier or diluent thereof.
    Type: Grant
    Filed: February 26, 1987
    Date of Patent: May 9, 1989
    Assignee: Medical Foundation of Buffalo, Inc.
    Inventor: Yoshio Osawa